255 related articles for article (PubMed ID: 34127041)
1. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
Staley BS; Milko LV; Waltz M; Griesemer I; Mollison L; Grant TL; Farnan L; Roche M; Navas A; Lightfoot A; Foreman AKM; O'Daniel JM; O'Neill SC; Lin FC; Roman TS; Brandt A; Powell BC; Rini C; Berg JS; Bensen JT
Trials; 2021 Jun; 22(1):395. PubMed ID: 34127041
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol.
Milko LV; Rini C; Lewis MA; Butterfield RM; Lin FC; Paquin RS; Powell BC; Roche MI; Souris KJ; Bailey DB; Berg JS; Powell CM
Trials; 2018 Jun; 19(1):344. PubMed ID: 29950170
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. The NYCKidSeq project: study protocol for a randomized controlled trial incorporating genomics into the clinical care of diverse New York City children.
Odgis JA; Gallagher KM; Suckiel SA; Donohue KE; Ramos MA; Kelly NR; Bertier G; Blackburn C; Brown K; Fielding L; Lopez J; Aguiniga KL; Maria E; Rodriguez JE; Sebastin M; Teitelman N; Watnick D; Yelton NM; Abhyankar A; Abul-Husn NS; Baum A; Bauman LJ; Beal JC; Bloom T; Cunningham-Rundles C; Diaz GA; Dolan S; Ferket BS; Jobanputra V; Kovatch P; McDonald TV; McGoldrick PE; Rhodes R; Rinke ML; Robinson M; Rubinstein A; Shulman LH; Stolte C; Wolf SM; Yozawitz E; Zinberg RE; Greally JM; Gelb BD; Horowitz CR; Wasserstein MP; Kenny EE
Trials; 2021 Jan; 22(1):56. PubMed ID: 33446240
[TBL] [Abstract][Full Text] [Related]
6. Improving access to exome sequencing in a medically underserved population through the Texome Project.
Vuocolo B; German RJ; Lalani SR; Murali CN; Bacino CA; Baskin S; Littlejohn R; Odom JD; McLean S; Schmid C; Nutter M; Stuebben M; Magness E; Juarez O; El Achi D; Mitchell B; Glinton KE; Robak L; Nagamani SCS; Saba L; Ritenour A; Zhang L; Streff H; Chan K; Kemere KJ; Carter K; ; Owen N; Vossaert L; Liu P; Bellen H; Wangler MF
Genet Med; 2024 Jun; 26(6):101102. PubMed ID: 38431799
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
Trosman JR; Weldon CB; Slavotinek A; Norton ME; Douglas MP; Phillips KA
Genet Med; 2020 Feb; 22(2):283-291. PubMed ID: 31501586
[TBL] [Abstract][Full Text] [Related]
8. Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.
Hill M; Ellard S; Fisher J; Fulop N; Knight M; Kroese M; Ledger J; Leeson-Beevers K; McEwan A; McMullan D; Mellis R; Morris S; Parker M; Tapon D; Baple E; Blackburn L; Choudry A; Lafarge C; McInnes-Dean H; Peter M; Ramakrishnan R; Roberts L; Searle B; Smith E; Walton H; Wynn SL; Han Wu W; Chitty LS
NIHR Open Res; 2022; 2():10. PubMed ID: 35935673
[TBL] [Abstract][Full Text] [Related]
9. Engaging community stakeholders in research on best practices for clinical genomic sequencing.
Griesemer I; Staley BS; Lightfoot AF; Bain L; Byrd D; Conway C; Grant TL; Leach B; Milko L; Mollison L; Porter N; Reid S; Smith G; Waltz M; Berg JS; Rini C; O'Daniel JM
Per Med; 2020 Nov; 17(6):435-444. PubMed ID: 33026293
[No Abstract] [Full Text] [Related]
10. Exome sequencing in the pediatric neuromuscular clinic leads to more frequent diagnosis of both neuromuscular and neurodevelopmental conditions.
Meyer AP; Ma J; Brock G; Hashimoto S; Cottrell CE; Mathew M; Hunter JM; Leung ML; Corsmeier D; Jayaraman V; Waldrop MA; Flanigan KM
Muscle Nerve; 2023 Nov; 68(6):833-840. PubMed ID: 37789688
[TBL] [Abstract][Full Text] [Related]
11. Parents' perceptions of personal utility of exome sequencing results.
Mollison L; O'Daniel JM; Henderson GE; Berg JS; Skinner D
Genet Med; 2020 Apr; 22(4):752-757. PubMed ID: 31857707
[TBL] [Abstract][Full Text] [Related]
12. The implementation of an enhanced clinical model to improve the diagnostic yield of exome sequencing for patients with a rare genetic disease: A Canadian experience.
Ediae GU; Lemire G; Chisholm C; Hartley T; Eaton A; Osmond M; Rojas SK; Huang L; Gillespie M; ; Sawyer SL; Boycott KM
Am J Med Genet A; 2023 Feb; 191(2):338-347. PubMed ID: 36331261
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series.
Taylor J; Craft J; Blair E; Wordsworth S; Beeson D; Chandratre S; Cossins J; Lester T; Németh AH; Ormondroyd E; Patel SY; Pagnamenta AT; Taylor JC; Thomson KL; Watkins H; Wilkie AOM; Knight JC
Genome Med; 2019 Jul; 11(1):46. PubMed ID: 31345272
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Whole Exome Sequencing for Diagnostic Odyssey Cases of an Individualized Medicine Clinic: The Mayo Clinic Experience.
Lazaridis KN; Schahl KA; Cousin MA; Babovic-Vuksanovic D; Riegert-Johnson DL; Gavrilova RH; McAllister TM; Lindor NM; Abraham RS; Ackerman MJ; Pichurin PN; Deyle DR; Gavrilov DK; Hand JL; Klee EW; Stephens MC; Wick MJ; Atkinson EJ; Linden DR; Ferber MJ; Wieben ED; Farrugia G;
Mayo Clin Proc; 2016 Mar; 91(3):297-307. PubMed ID: 26944241
[TBL] [Abstract][Full Text] [Related]
16. Genomic knowledge in the context of diagnostic exome sequencing: changes over time, persistent subgroup differences, and associations with psychological sequencing outcomes.
Rini C; Henderson GE; Evans JP; Berg JS; Foreman AKM; Griesemer I; Waltz M; O'Daniel JM; Roche MI
Genet Med; 2020 Jan; 22(1):60-68. PubMed ID: 31312045
[TBL] [Abstract][Full Text] [Related]
17. Understanding access to genomics in an ethnically diverse south Florida population: A comparison of demographics in odyssey and rapid whole genome sequencing programs.
Hussain SB; Quittner AL; Brown M; Li-Rosi AM
J Genet Couns; 2020 Aug; 29(4):553-561. PubMed ID: 32277851
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic yield of clinical exome sequencing in adulthood in medical genetics clinics.
Mainali A; Athey T; Bahl S; Hung C; Caluseriu O; Chan A; Eaton A; Ghai SJ; Kannu P; MacPherson M; Niederhoffer KY; Siriwardena K; Mercimek-Andrews S
Am J Med Genet A; 2023 Feb; 191(2):510-517. PubMed ID: 36401557
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
